Nomura Holdings’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-35,500
Closed -$7.73M 2614
2021
Q1
$7.73M Buy
35,500
+10,750
+43% +$2.02M 0.02% 417
2020
Q4
$2.87M Sell
24,750
-60,250
-71% -$6.75M ﹤0.01% 723
2020
Q3
$8.29M Buy
85,000
+78,000
+1,114% +$8.98M 0.02% 391
2020
Q2
$858K Buy
+7,000
New +$794K ﹤0.01% 749
2020
Q1
Sell
-47,257
Closed -$4.93M 1323
2019
Q4
$4.93M Buy
47,257
+2,257
+5% +$253K 0.02% 450
2019
Q3
$5M Buy
+45,000
New +$6.83M 0.02% 464
2017
Q2
Sell
-77,687
Closed -$9.39M 1662
2017
Q1
$9.39M Buy
+77,687
New +$9.53M 0.02% 321

Other funds holding GWPH

Nomura Holdings's GWPH Position: Q2 2021 in Review

Nomura Holdings sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 35,500 shares — an estimated $7.73M sold.

Nomura Holdings first reported a position in GWPH in Q1 2017 and held it in 7 quarters. The position peaked at $9.39M in Q1 2017. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Nomura Holdings reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Nomura Holdings sold 35,500 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $7.73M.
  • Nomura Holdings first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2017 and held it in 7 quarters.
  • Nomura Holdings's GW Pharmaceuticals Plc American Depositary Shares position peaked at $9.39M in Q1 2017.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Nomura Holdings's 13F filing for Q2 2021, filed 16 Aug 2021.